Works matching IS 00278874 AND DT 2014 AND VI 106 AND IP 2


Results: 44
    1
    2
    3

    Crizotinib in advanced, chemoresistant anaplastic lymphoma kinase-positive lymphoma patients.

    Published in:
    2014
    By:
    • Gambacorti Passerini, Carlo;
    • Farina, Francesca;
    • Stasia, Alessandra;
    • Redaelli, Sara;
    • Ceccon, Monica;
    • Mologni, Luca;
    • Messa, Cristina;
    • Guerra, Luca;
    • Giudici, Giovanni;
    • Sala, Elena;
    • Mussolin, Lara;
    • Deeren, Dries;
    • King, Michael H;
    • Steurer, Michael;
    • Ordemann, Rainer;
    • Cohen, Amos M;
    • Grube, Matthias;
    • Bernard, Lea;
    • Chiriano, Gianpaolo;
    • Antolini, Laura
    Publication type:
    Journal Article
    4

    Response.

    Published in:
    2014
    By:
    • Berry, Donald A
    Publication type:
    Journal Article
    5

    Response.

    Published in:
    2014
    By:
    • Risques, Rosa Ana;
    • Ussakli, Cigdem;
    • Salk, Jesse J;
    • Rabinovitch, Peter S;
    • Brentnall, Teresa A
    Publication type:
    Journal Article
    6
    7

    Response.

    Published in:
    2014
    By:
    • Haines, Ian E;
    • Gabor Miklos, George L
    Publication type:
    Journal Article
    8

    Response.

    Published in:
    2014
    By:
    • Arem, Hannah;
    • Park, Yikyung;
    • Pelser, Colleen;
    • Barbash, Rachel Ballard;
    • Irwin, Melinda L;
    • Hollenbeck, Albert;
    • Gierach, Gretchen L;
    • Brinton, Louise A;
    • Pfeiffer, Ruth M;
    • Matthews, Charles E
    Publication type:
    Letter
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21

    Crizotinib in Advanced, Chemoresistant Anaplastic Lymphoma Kinase--Positive Lymphoma Patients.

    Published in:
    JNCI: Journal of the National Cancer Institute, 2014, v. 106, n. 2, p. 1, doi. 10.1093/jnci/djt378
    By:
    • Gambacorti Passerini, Carlo;
    • Farina, Francesca;
    • Stasia, Alessandra;
    • Redaelli, Sara;
    • Ceccon, Monica;
    • Mologni, Luca;
    • Messa, Cristina;
    • Guerra, Luca;
    • Giudici, Giovanni;
    • Sala, Elena;
    • Mussolin, Lara;
    • Deeren, Dries;
    • King, Michael H.;
    • Steurer, Michael;
    • Ordemann, Rainer;
    • Cohen, Amos M.;
    • Grube, Matthias;
    • Bernard, Lea;
    • Chiriano, Gianpaolo;
    • Antolini, Laura
    Publication type:
    Article
    22
    23
    24

    A Model Too Far.

    Published in:
    2014
    By:
    • Freidlin, Boris;
    • Korn, Edward L.
    Publication type:
    Editorial
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35

    Comparative Proteome Analysis Revealing an 11-Protein Signature for AggressiveTriple-Negative Breast Cancer.

    Published in:
    JNCI: Journal of the National Cancer Institute, 2014, v. 106, n. 2, p. 1, doi. 10.1093/jnci/djt376
    By:
    • Ning Qing Liu;
    • Stingl, Christoph;
    • Look, Maxime P.;
    • Smid, Marcel;
    • Braakman, René B. H.;
    • De Marchi, Tommaso;
    • Sieuwerts, Anieta M.;
    • Span, Paul N.;
    • Sweep, Fred C. G. J.;
    • Linderholm, Barbro K.;
    • Mangia, Anita;
    • Paradiso, Angelo;
    • Dirix, Luc Y.;
    • Van Laere, Steven J.;
    • Luider, Theo M.;
    • Martens, John W. M.;
    • Foekens, John A.;
    • Umar, Arzu
    Publication type:
    Article
    36
    37
    38
    39
    40

    NEWS.

    Published in:
    JNCI: Journal of the National Cancer Institute, 2014, v. 106, n. 2, p. 8, doi. 10.1093/jnci/dju038
    Publication type:
    Article
    41
    42
    43

    Navigating Cancer Treatment.

    Published in:
    JNCI: Journal of the National Cancer Institute, 2014, v. 106, n. 2, p. 2, doi. 10.1093/jnci/dju031
    By:
    • Ullman, Kurt
    Publication type:
    Article
    44